Human pathology

Home page > D. Systemic pathology > Genetic and developmental anomalies > malignant rhabdoid tumor

malignant rhabdoid tumor

rhabdoid tumor, MRT

Epidemiology

- infancy and early childhood
- median age: 11 mths
- unbalanced sex ratio (1.5M/1F)

Synopsis

- uncertain histogenesis

Localization

- kidney
- central nervous system
- soft tissues
- paratesticular region (14696145) (3 cases described - 2004)
- mesentery (14507006)

Predisposition

- rhabdoid tumor predisposition syndrome : constitutional mutation in the SMARCB1 (hSNF5/INI1) gene at 22q11.2 (MIM.601607)

Cytogenetics

- normal karyotype

- 22q11 anomalies (8818656)

- 8q24 rearrangements

- inv(11)(p13p15) (11004236)

Molecular biology

- LOH at 22q11.2
- LOH at 11p15.5
- inactivating mutation of the SMARCB1 (hSNF5/INI1) gene at 22q11.2 (MIM.601607)

Differential diagnosis

- rhabdoid cell tumors

Prognosis

- highly aggressive tumor
- 80% mortality rate with frequent metastases, predominantly pulmonary
- better outcome for girls (> 50% survival) than for boys (10%) (one study)

P.S.


- AGCOH